(Q33449292)

26 July 2017

title

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial (English)

1 reference

multicenter clinical trial

26 July 2017

main subject

0 references

hemolytic-uremic syndrome

1 reference

10

Remuzzi G

1 reference

26 July 2017

Rizzoni G

1

1 reference

26 July 2017

Claris-Appiani A

2

1 reference

26 July 2017

Edefonti A

3

1 reference

26 July 2017

Facchin P

4

1 reference

26 July 2017

Franchini F

5

1 reference

26 July 2017

Gusmano R

6

1 reference

26 July 2017

Imbasciati E

7

1 reference

26 July 2017

Pavanello L

8

1 reference

26 July 2017

Perfumo F

9

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 February 1988

1 reference

The Journal of Pediatrics

26 July 2017

published in

1 reference

26 July 2017

volume

112

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

284-290

1 reference

Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Inherited plasma factor deficiency in haemolytic-uraemic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Prostacyclin therapy of thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Heparin therapy in the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Treatment of Thrombotic Thrombocytopenic Purpura with Plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Intravenous prostacyclin in thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Hemolytic uremic syndrome. Results of treatment with hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Renal microangiopathy of the hemolytic-uremic syndrome in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Haemolytic-uraemic syndrome: an analysis of prognostic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Plasmapheresis in the haemolytic-uraemic syndrome in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Prostanoids in hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

Haemolytic uraemic syndrome: therapeutic effect of plasma infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2888%2980071-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(88)80071-4

1 reference

26 July 2017

1 reference